Navigation Links
Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
Date:8/25/2010

heir use has been limited to cases where human donor tissue fails repeatedly or cannot be used. Moreover, apart from the US, in most countries, tissue donation and banking systems do not exist.

About FibroGen's recombinant human collagens

FibroGen is the only producer of highly purified, fully characterized recombinant human type III collagen (rhCIII) intended to replace similar animal- or human-derived materials currently used in a variety of medical, pharmaceutical, and consumer applications. FibroGen uses proprietary recombinant methodology in a yeast expression system with human DNA sequences to develop synthetic versions of human collagens essentially identical to the native protein. Mixtures of various collagen types found in animal-sourced collagen are nearly impossible to segregate. FibroGen has been able to produce specific types of recombinant human collagen (e.g., types I or III) consistently and reproducibly. FibroGen has developed simple, scalable purification processes that provide highly purified and reproducible lots of protein in any desired quantity, and employs a series of rigorous analytical tests to ensure lot-to-lot consistency and high quality.


'/>"/>

Contact: Laura Hansen
lhansen@fibrogen.com
415-978-1433
FibroGen, Inc.
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants
2. Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage
3. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
4. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
5. STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
6. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
7. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Recombinant C-Reactive Protein
9. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
10. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
11. New Recombinant XYNTHA Now Available for Patients with Hemophilia A
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Strategic marketing and branding agency, Red ... Able&Co. , The agency was founded in 2008 by ... inception, continuing to expand its business each year. “We ... a core focus on branding and marketing strategy. As ... and visual identity to reflect who we have become ...
(Date:3/6/2015)... , March 6, 2015 According ... Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, ... Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to ... is expected to reach $14.7 Billion in 2019 from ... 7.5% from 2014 to 2019. Browse ...
(Date:3/6/2015)... , March 6, 2015  Attorney Advertising-- Bronstein, Gewirtz ... behalf of purchasers of the securities of Orexigen ... OREX -News).  Such investors are advised ... investor relations coordinator Eitan Kimelman at ... investigation concerns whether Orexigen and certain of its ...
(Date:3/6/2015)... March 6, 2015 BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... XIAPEX ®  in the EU, announced today that it ... at 8:30 a.m. ET on Friday, March 13, 2015 ... financial results and provide a corporate update. ...
Breaking Biology Technology:Red House Group Reveals New Identity as Able&Co. 2Soft Tissue Repair Market worth $14.7 Billion in 2019 2Soft Tissue Repair Market worth $14.7 Billion in 2019 3Soft Tissue Repair Market worth $14.7 Billion in 2019 4SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Orexigen Therapeutics, Inc. 2BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2
... ... Inc. 5000 , ... Boston, MA (PRWEB) August 13, 2009 -- Inc. magazine announced on Wednesday its 2009 ... a diversified technology solutions company and a leader in web-database solutions, healthcare intelligence and ...
... National Physical Laboratory (NPL) in Teddington have developed imaging technology ... minimise wastage and solve an impending labour shortage for UK ... to 60% - which can mean up to 100,000 of ... farmers who were consulted during research. Falling number of migrant ...
... , , OMAHA, Neb., Aug. ... the quarter ended June 30, 2009. The Company,s financial results are presented in ... , The Company reported a net loss of $730,000 or $0.01 per ... $101,000 or $0.00 per share for the second quarter of 2008. , ...
Cached Biology Technology:Massachusetts Technology Corporation Named to Inc. 5000 List of Fastest Growing Private Companies 2UK scientists developing intelligent harvesting robot to save farms up to 100,000 a year 2Transgenomic, Inc. Reports Second Quarter 2009 Results 2Transgenomic, Inc. Reports Second Quarter 2009 Results 3Transgenomic, Inc. Reports Second Quarter 2009 Results 4Transgenomic, Inc. Reports Second Quarter 2009 Results 5Transgenomic, Inc. Reports Second Quarter 2009 Results 6Transgenomic, Inc. Reports Second Quarter 2009 Results 7Transgenomic, Inc. Reports Second Quarter 2009 Results 8
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... is available in German . , The hairs ... a 10 per cent decrease in fuel consumption. The plant has ... under water. Researchers at the University of Bonn, Rostock and Karlsruhe ... how the fern does this. Their results can possibly be used ...
... of the relationship between testosterone and natural selection ... defied some expectations and confirmed others. Scientists ... Indiana University-Purdue University Indianapolis, and the University of ... The American Naturalist (now online) that ...
... Scientists (AAPS) is a professional, scientific society of ... and other research institutes worldwide. Founded in 1986, ... exchange of knowledge among scientists to enhance their ... programs, on-going education, information resources, opportunities for networking, ...
Cached Biology News:Bionic coating could help ships to economize on fuel 2Natural selection for moderate testosterone surprises scientists 2Natural selection for moderate testosterone surprises scientists 3Natural selection for moderate testosterone surprises scientists 4
The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll...
... Klein Taq is a derivative of Taq ... truncated Thermus aquaticus DNA polymerase. Expressed from ... initiates at Met236, bypassing the 5'-3' exonuclease ... enzyme reveals a highly active and even ...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
96 Well Base Plate...
Biology Products: